Your institution may have access to this item. Find your institution then sign in to continue.
Title
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo.
Authors
Daoussis, Dimitrios; Andonopoulos, Andrew P
Abstract
Several lines of evidence from basic research indicate that B cells may contribute to the pathogenesis of systemic sclerosis. Clinical studies as well have provided preliminary data pointing to the direction that B-cell depletion with rituximab might be a therapeutic option for patients with this debilitating disease.